Strength
100; 33 U/mL; ug/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024576105
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
INSULIN GLARGINE; LIXISENATIDEApproval Type
Biologic (BLA)
FDA Application
BLA208673On Market Since
11/21/2016
Pharmacological Classes
GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists
Insulin Analog
Insulin
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
HUMULIN 70-30 VIAL
Brand
00002871501•Eli Lilly and Company
$4.2626
per ML
HUMULIN R 100 UNIT/ML VIAL
Brand
00002821501•Eli Lilly and Company
$4.2660
per ML
HUMULIN N 100 UNIT/ML VIAL
Brand
00002831501•Eli Lilly and Company
$4.2686
per ML
NOVOLIN R 100 UNIT/ML VIAL
Brand
00169183311•Novo Nordisk
$4.6226
per ML
NOVOLIN N 100 UNIT/ML VIAL
Brand
00169183411•Novo Nordisk
$4.6249
per ML
NOVOLIN 70-30 100 UNIT/ML VIAL
Brand
00169183711•Novo Nordisk
$4.6290
per ML
AFREZZA (REGULAR INSULIN) 4 UNIT CARTRIDGE
Brand
47918087490•Mannkind Corporation
$5.1957
per EA
NOVOLIN R 100 UNIT/ML FLEXPEN
Brand
00169300315•Novo Nordisk
$5.8194
per ML
NOVOLIN 70-30 FLEXPEN
Brand
00169300715•Novo Nordisk
$5.8261
per ML
NOVOLIN N 100 UNIT/ML FLEXPEN
Brand
00169300415•Novo Nordisk
$5.8268
per ML